Two New Physicians at UNC!

We are very excited to announce the arrival of Dr. Anne W. Beaven to be the Director of the UNC Lymphoma Program. Dr. Beaven, who completed her medical training at UNC, returns after a ten-year stint at Duke University managing their lymphoma clinic. She is glad to be a Tarheel again and is particularly excited about the rapidly growing UNC lymphoma program, which now includes three doctors specializing in lymphoma: Dr. Chris Dittus, Dr. Natalie Grover and Dr. Beaven. In the coming years Dr. Beaven will help to lead our growth by providing excellent patient care as well as expanding the number of clinical trials open for our patients. Our clinical research is notable for UNC developed trials of chimeric antigen receptor T cell therapy, more commonly known as Car-T therapy. This is an innovative therapy designed to harness the patient’s own immune system to help fight off their cancer. Dr. Beaven treats all lymphomas but has a special interest in the T cell lymphomas and, along with UNC dermatologist Dr. Edith Bowers, she will be starting up a multidisciplinary Cutaneous T Cell Lymphoma Clinic to better treat this underserved group of patients.

We are equally as excited to announce that Dr. Natalie Grover will be joining the UNC Lymphoma Program as well. Dr. Grover is excited to be staying at UNC and joining the lymphoma program after completing her fellowship in hematology/oncology here. She completed her internal medicine residency at the University of Virginia and obtained her medical degree from Case Western Reserve University. Dr. Grover’s research interests include novel treatment strategies in lymphoma, particularly immunotherapy, and she is currently involved in the clinical trials of chimeric antigen receptor T-cell (CAR-T) therapy for patients with lymphoma. She is looking forward to continuing to care for our lymphoma patients and developing better treatment strategies for these patients.